Chad M. Michener

Cleveland Clinic

Papers

4

Total Citations

76

H-Index

4

About

Chad M. Michener is a leading gynecologic oncologist whose research is reshaping surgical practice for women with gynecologic cancers. His work centers on the safety, efficacy, and outcomes of minimally invasive surgery (MIS), particularly in endometrial and ovarian cancer. Dr. Michener has made critical contributions by rigorously evaluating surgical platforms—comparing multiport, single-port, and robotic-assisted laparoscopy—to determine their impact on recurrence and survival. His 2019 study on this topic, with 36 citations, provides vital evidence for surgical decision-making. He is also at the forefront of investigating laparoscopic cytoreduction after neoadjuvant chemotherapy for high-grade epithelial ovarian cancer, a 2024 study (22 citations) that addresses the urgent need for high-quality data on MIS in advanced disease. Further, his work on vaginal cuff dehiscence after laparoscopic hysterectomy (12 citations) and factors influencing same-day discharge for endometrial cancer patients (6 citations) directly improves perioperative care and patient outcomes. Dr. Michener’s research is not only highly cited but also immediately applicable, guiding surgeons toward safer, more effective, and patient-centered approaches in complex oncologic surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
76
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgery
36 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago